/Investor DB

Stage 1 Ventures — 2015 Investments

4 investments dated 2015 · listed companies and verified rows first · show all

Eko Healthekohealth.comin𝕏Seed · Mar 2015 · $2M

Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Connor Landgraf(Co-Founder and CEO)inTyler CrouchinJason Bellet(Co-Founder and Chief Business Officer)in

Co-investorsQuesta CapitalHighland Capital PartnersArtis VenturesBetter Ventures Central LlcCAL InnovationCalifornia Innovation Fund+15 more

Reticarereticare.comMar 2015

Reticare develops scientifically validated eye-protection products, such as screen filters and glasses, that absorb high-energy blue and green light emitted by digital screens to reduce cumulative retinal damage.

Advanced ManufacturingConsumerDirect to ConsumerHardwareHealthtechWellness & FitnessCambridge, US

Celia Sánchez-Ramos(Researcher (UCM))Nilo García Manchado(CEO y Fundador)Dra. Celia Sánchez-Ramos(Directora Científica e Inventora, cofundadora)Roque Garcia(Vice President, Secretary and Treasurer of Issuer)Nilo Garcia(Chief Executive Officer and President of Issuer)

Viral Gainsviralgains.comin𝕏Dec 2015

ViralGains is an advertising platform that collects zero-party consumer data by gathering real-time feedback within ads, using it to build more personalized ad experiences.

AdTechData & InfrastructureMarketing TechSaaSBoston, US

Dan Levin(President, COO, and Co-Founder)inJay Singh(Executive Officer, Director)Kate Willett(Executive Officer, Director)Tod Loofbourrow(Chairman and CEO)inCindy Brown(CRO)inSafaa Lafnoune(VP of Product)in

Co-investors500 GlobalBantam GroupFirst AnalysisGolden SeedsLaunchCapitalMontage Capital+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Gemini Data Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.